Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.

Benzer Materyaller

• In vitro activity of tosufloxacin, a new quinolone, against respiratory pathogens derived from cystic fibrosis sputum.
  Yazar:: Arguedas, A G, ve diğerleri
  Baskı/Yayın Bilgisi: (1990)
• In vitro activity of E-1040, a 3-substituted cephalosporin, against pathogens from cystic fibrosis sputum.
  Yazar:: Stutman, H R, ve diğerleri
  Baskı/Yayın Bilgisi: (1990)
• In vitro activity of sparfloxacin (AT-4140), a new quinolone agent, against invasive isolates from pediatric patients.
  Yazar:: Akaniro, J C, ve diğerleri
  Baskı/Yayın Bilgisi: (1992)
• In vitro activities of 4-quinolones against the fish pathogen Aeromonas salmonicida.
  Yazar:: Barnes, A C, ve diğerleri
  Baskı/Yayın Bilgisi: (1990)
• Comparative in vitro activities of new quinolones against coryneform bacteria.
  Yazar:: Martínez-Martínez, L, ve diğerleri
  Baskı/Yayın Bilgisi: (1994)